Rezolute
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism (NCT06881992) | Rezolute | 2025-04-16 |
| RZ358 Treatment for Congenital Hyperinsulinism (NCT06208215) | Rezolute | 2024-01-11 |
| Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) (NCT05712720) | Rezolute | 2023-02-06 |
Track Rezolute automatically
Every clearance here is in the API, with alerts when new ones post.